Dr Jeffrey Paul Lagasse, MD | |
6708 Kenney Way, Clinton, WA 98236-8504 | |
(360) 579-2744 | |
Not Available |
Full Name | Dr Jeffrey Paul Lagasse |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 6708 Kenney Way, Clinton, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134475577 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 00032452 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jeffrey Paul Lagasse, MD Po Box 637, Freeland, WA 98249-0637 Ph: (360) 579-2744 | Dr Jeffrey Paul Lagasse, MD 6708 Kenney Way, Clinton, WA 98236-8504 Ph: (360) 579-2744 |
News Archive
Fish possess a number of different mechanisms for protection against harmful substances in an aquatic environment. These include, for example, molecular transport systems, such as the so called ABC (ATP binding cassette) transporters, which prevent the penetration of toxic substances into cells. ABC transporters have been well investigated for mammals.
The cardiac pacemaker of the future could be powered by the heart itself, according to researchers at Shanghai Jiao Tong University.
Movie characters from the Terminator to the Bionic Woman use bionic eyes to zoom in on far-off scenes, have useful facts pop into their field of view, or create virtual crosshairs.
The European Union has funded a 4 year project called TAILORED-Treatment with € 6.000.000,-. The main goal of TAILORED -Treatment is to establish a strategy that can be used to increase the effectiveness of antibiotic treatment, reduce any potential side-effects of therapy, and help limit the emergence of antimicrobial resistance in hospitalized children and adults. The project will be coordinated by Erasmus MC, Rotterdam, the Netherlands.
New research has provided more evidence that an innovative treatment strategy may help prevent brain swelling and death in stroke patients. J. Marc Simard, professor of neurosurgery at the University of Maryland School of Medicine, along with colleagues at Yale University and Massachusetts General Hospital, found that Cirara, an investigational drug, powerfully reduced brain swelling and death in patients who had suffered a type of large stroke called malignant infarction, which normally carries a high mortality rate.
› Verified 7 days ago